Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06655623
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-15
Brief Title:
A Multiple Case Study of Schema Therapy for Difficult-to-treat Depression- DEPRE-STCase
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Multiple Case Study of Schema Therapy for Difficult-to-treat Depression - DEPRE-STCase
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical multiple case study seeks to expand the knowledge of how schema therapy could function as an intervention for difficult-to-treat depression The study will explore in depth the course of a 30 session treatment with schema therapy conducted over approximately one year on three individual patients at two different psychiatric treatment sites
Together the data from this study will inform about the feasibility of schema therapy for difficult-to-treat depression as well as form the base for recommendations in adapting schema therapy for this particular patient group
Together the data from this study will inform about the feasibility of schema therapy for difficult-to-treat depression as well as form the base for recommendations in adapting schema therapy for this particular patient group
Detailed Description:
The study is part of a larger randomized controlled study the DEPRE-ST study clinicaltrialsgov registration NCT05833087Arendt et al 2024 The study participants will also be part of the large trial and will be recruited for the current case study when their randomization status is being revealed ie they are randomized to schema therapy
In addition to the data collected in the DEPRE-ST trial the patients will for each session self-report depression symptoms before the session and two different evaluations of the session after the session In addition the patients level of the schema therapy construct of Healthy Adult Mode will be measured by self-report once monthly
And finally the therapist will be interviewed at the end of the treatment course about important aspects of the content and outcome of the therapy Video recordings of each session will provide detailed information about these aspects and the interventions used in therapy
The most important focus for the publication for this study will be to describe the trajectories of therapy for the participants including content effect and subjective evaluations of therapists and participants Also the feasibility and adaptability of schema therapy for difficult-to-treat depression will be evaluated
Data from outcome measurements will be presented descriptively only Interview and video data will be compared with the outcomes measurements to reveal important events and how they might be reflected in the replies to post-session evaluation questionnaires Session Evaluation Questionnaire and Helpful Aspects of Therapy and in the course of the participants self-reported depression symptoms and Healthy Adult mode
In addition to the data collected in the DEPRE-ST trial the patients will for each session self-report depression symptoms before the session and two different evaluations of the session after the session In addition the patients level of the schema therapy construct of Healthy Adult Mode will be measured by self-report once monthly
And finally the therapist will be interviewed at the end of the treatment course about important aspects of the content and outcome of the therapy Video recordings of each session will provide detailed information about these aspects and the interventions used in therapy
The most important focus for the publication for this study will be to describe the trajectories of therapy for the participants including content effect and subjective evaluations of therapists and participants Also the feasibility and adaptability of schema therapy for difficult-to-treat depression will be evaluated
Data from outcome measurements will be presented descriptively only Interview and video data will be compared with the outcomes measurements to reveal important events and how they might be reflected in the replies to post-session evaluation questionnaires Session Evaluation Questionnaire and Helpful Aspects of Therapy and in the course of the participants self-reported depression symptoms and Healthy Adult mode
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None